Driehaus Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-121,698
Closed -$11.3M 470
2021
Q4
$11.3M Buy
+121,698
New +$8.02M 0.12% 227
2018
Q3
Sell
-270,174
Closed -$11.8M 573
2018
Q2
$11.8M Buy
270,174
+16,955
+7% +$729K 0.4% 69
2018
Q1
$10M Buy
+253,219
New +$9.85M 0.35% 65

Driehaus Capital Management's ARNA Position: Q1 2022 in Review

Driehaus Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 121,698 shares — an estimated $11.3M sold.

Driehaus Capital Management first reported a position in ARNA in Q1 2018 and held it in 3 quarters. The position peaked at $11.8M in Q2 2018. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Driehaus Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Driehaus Capital Management sold 121,698 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $11.3M.
  • Driehaus Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 3 quarters.
  • Driehaus Capital Management's Arena Pharmaceuticals Inc position peaked at $11.8M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Driehaus Capital Management's 13F filing for Q1 2022, filed 16 May 2022.